BioLife4D Corporation (SAVU)
BioLife4D will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$5.20 - $7.20
Shares Offered
1,596,154
Deal Size
$9.90M

BioLife4D Statistics

Total Valuation

BioLife4D has a market cap or net worth of $32.31 million. The enterprise value is $32.89 million.

Market Cap 32.31M
Enterprise Value 32.89M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

BioLife4D has 5.21 million shares outstanding.

Current Share Class n/a
Shares Outstanding 5.21M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -17.29

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Capital (ROIC) -556.73%
Revenue Per Employee n/a
Profits Per Employee -$279,643
Employee Count 7
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -2.25M
Pretax Income -1.96M
Net Income -1.96M
EBITDA -1.84M
EBIT -1.85M
Earnings Per Share (EPS) -$0.38
Full Income Statement

Balance Sheet

The company has $442,297 in cash and $1.02 million in debt, giving a net cash position of -$576,919 or -$0.11 per share.

Cash & Cash Equivalents 442,297
Total Debt 1.02M
Net Cash -576,919
Net Cash Per Share -$0.11
Equity (Book Value) -615,476
Book Value Per Share -0.12
Working Capital 3,248
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.21 million and capital expenditures -$16,300, giving a free cash flow of -$1.22 million.

Operating Cash Flow -1.21M
Capital Expenditures -16,300
Free Cash Flow -1.22M
FCF Per Share -$0.23
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BioLife4D does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -6.06%
FCF Yield -3.78%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1